ArticleCell2019
Effector T
Abstract read
In one paragraph
Article in Cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers.
0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
115 citing papers in PubMed, 171 citations in OpenAlex.
- Single-Cell Profiling Identifies Skin-Resident Memory CD4European journal of immunology · 2026Article
- Whole-body irradiation causes long-term impairments in the maintenance and function of naïve CD4 T cells specific for self- and non-self-antigens.Journal of immunology (Baltimore, Md. : 1950) · 2026Article
- Dipeptidyl peptidase 3 sets the threshold for immune activation and survival during experimental bacterial infection.Nature communications · 2026Article
- Impact of Biologic Treatment Duration on Drug-Free Remission in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study.Dermatology and therapy · 2026Article
- Host-Pathogen Interactions Leading to Pneumonia Pathogenesis.Clinics in chest medicine · 2026Review
- Empowering fungal infection research with single-cell RNA sequencing.Communications biology · 2026Review
- Expression of CD103 facilitates localization and activation of CD4Mucosal immunology · 2026Article
- Carbapenem resistance and hypervirulence iniScience · 2026Review
- Evaluation of humoral and cellular immune responses induced by a novel YidRv subunit vaccine from hypervirulentBiotechnologia · 2026Article
- Second-order regulation: IFN-γ suppresses IL-17A-mediated type 3 inflammation.Frontiers in immunology · 2026Article
- T cell-macrophage interactions in tuberculosis: What we've got here is failure to communicate.Journal of internal medicine · 2026Review
- Live auxotrophic vaccines contribute to protection against chronic lung infections caused byFrontiers in immunology · 2026Article
- AFrontiers in tuberculosis · 2026Article
- Glycolysis maintains effector function of lung Th17 TRM cells in precision cut lung slices.iScience · 2025Article
- IL-15 Promotes Inflammatory Th17 Cells in the Intestine.Inflammatory bowel diseases · 2025Article
- TScience immunology · 2025Article
- Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design.Nature reviews. Immunology · 2025Review
- Alpha hemolysin enhances the immune response by modulating dendritic cell differentiation via ADAM10-Notch signaling.Signal transduction and targeted therapy · 2025Article
- CD4Immunology and cell biology · 2025Review
- Inflammation-Induced Th17 Cells Synergize with the Inflammation-Trained Microbiota to Mediate Host Resiliency Against Intestinal Injury.Inflammatory bowel diseases · 2025Article
55 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 10 institutions in 5 countries.
Maria Carolina Amezcua VeselyDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.
Paris PallisDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA.
Piotr BieleckiDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA.
Jun Siong LowDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA.
Jun ZhaoDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA; Department of Pathology, Yale School of Medicine, New Haven, CT 06510, USA; Program of Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA.
Christian C D HarmanDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.
Lina KroehlingDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA.
Ruaidhrí JacksonDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA.
Will BailisDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA.
Paula Licona-LimónDepartamento de Biología Celular y del Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, México.
Hao XuDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA.
Norifumi IijimaDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA.
Padmini S PillaiDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA; Koch Institute for Integrative Cancer Research and Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Daniel H KaplanDepartment of Dermatology and Immunology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Casey T WeaverDepartments of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Yuval KlugerDepartment of Pathology, Yale School of Medicine, New Haven, CT 06510, USA; Program of Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520, USA; Applied Mathematics Program, Yale University, New Haven, CT 06511, USA.
Monika S KowalczykBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Akiko IwasakiDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.
Joao P PereiraDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA.
Enric EspluguesDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA; Laboratory of Molecular and Cellular Immunology, Principe Felipe Research Center (CIPF), 46012 Valencia, Spain.
Nicola GaglianiDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA; I. Medical Department and Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf 20246 Hamburg, Germany; Immunology and Allergy Unit, Department of Medicine Solna, Karolinska Institute, 17176 Stockholm, Sweden. Electronic address: n.gagliani@uke.de.
Richard A FlavellDepartment of Immunobiology, School of Medicine, Yale University, New Haven, CT, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA. Electronic address: richard.flavell@yale.edu.
Yale University · USHoward Hughes Medical Institute · USApplied Mathematics (United States) · USBroad Institute · USCentro de Investigacion Principe Felipe · ESKarolinska Institutet · SEMassachusetts Institute of Technology · USUniversidad Nacional Autónoma de México · MXUniversity of Alabama at Birmingham · USUniversity of Pittsburgh · US
Funding
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9MCellular and molecular analysis of B lymphocyte development and selectionR01AI113040 · NIAID · YALE UNIVERSITY · PI JOAO PEREIRA · 2014 to 2026
$6.0MRegulated Activation of Latent-TGFb Determines Leukocyte Occupancy of the Epidermal NicheR01AR060744 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAPLAN, DANIEL H · 2011 to 2020
$4.0MB cell based protection against recurrent herpesR01AI127429 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2017 to 2021
$2.1MEFFICIENT METHODS FOR CALIBRATION, CLUSTERING, VISUALIZATION AND IMPUTATION OF LARGE scRNA-seq DATAR01GM131642 · NIGMS · YALE UNIVERSITY · PI KLUGER, YUVAL · 2019 to 2022
$1.6MTh17 Pathway Plasticity in the Pathogenesis of Inflammatory Bowel DiseaseR01DK103744 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEAVER, CASEY T · 2015 to 2018
$1.3MEFFICIENT SPECTRAL APPROACHES FOR FINDING UNDERLYING STRUCTURES IN BIG DATAR01HG008383 · NHGRI · YALE UNIVERSITY · PI KLUGER, YUVAL · 2016 to 2018
$1.2MHoward Hughes Medical InstituteNCATS NIH HHS UL1 TR001863NHGRI NIH HHS R01 HG008383NIAID NIH HHS R01 AI113040NIAID NIH HHS R01 AI127429NIAMS NIH HHS R01 AR060744NIDDK NIH HHS R01 DK103744NIGMS NIH HHS R01 GM131642
Abstract
Adaptive immunity provides life-long protection by generating central and effector memory T cells and the most recently described tissue resident memory T (T
Indexed as
AnimalsCD4-Positive T-LymphocytesDiphtheria ToxinDisease Models, AnimalFemaleImmunologic MemoryInterleukin-17Klebsiella InfectionsKlebsiella pneumoniaeLungMiceMice, Inbred C57BLTh17 CellsDiphtheria ToxinInterleukin-17exT(H)17Fate mappingIL-17IL-7T(H)17Tissue resident memory CD4 T cells
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.